djledda.de main
You can not select more than 25 topics Topics must start with a letter or number, can include dashes ('-') and can be up to 35 characters long.
 
 

933 rivejä
73 KiB

  1. <html>
  2. <head><title>BSE - mad cow - scrapie, etc.: Stimulated amyloid degeneration and the toxic fats</title></head>
  3. <body>
  4. <h1>
  5. BSE - mad cow - scrapie, etc.: Stimulated amyloid degeneration and the toxic fats
  6. </h1>
  7. <article class="posted">
  8. <p>
  9. I have written before about the protective effects of carbon dioxide and progesterone, especially for
  10. the brain, and how the structure of cell water is affected by adsorbed and dissolved materials, and by
  11. metabolic energy. In the high energy (rested) state, cell water behaves as if it were colder than its
  12. real temperature, and this affects the behavior of proteins and fats in the cell, allowing “oily”
  13. surfaces to remain in contact with the more orderly water. Carbon dioxide spontaneously combines with
  14. the amino groups in proteins, stabilizing the normal functional conformation. The loss of carbon dioxide
  15. affects the structure of all proteins in the body, and the loss of cellular energy affects the structure
  16. of the intracellular proteins and their associated molecules.
  17. </p>
  18. <p>
  19. In scrapie and many other degenerative diseases (the amyloidoses), proteins condense into fibrils that
  20. tend to keep enlarging, with a variety of very harmful effects. The condensation of the “amyloid”
  21. proteins is sensitive to temperature, and a slight increase in the disorder of the water can induce
  22. functional proteins to change their conformation so that they spontaneously associate into fibrous
  23. masses. In the absence of sufficient carbon dioxide, all proteins are susceptible to structural
  24. alteration by the addition of sugars and fats and aldehydes, especially under conditions that favor
  25. lipid peroxidation.
  26. </p>
  27. <p>
  28. The amyloidoses affect different tissues in different ways, but when they occur in the brain, they
  29. produce progressive loss of function, with the type of protein forming the fibrils determining the
  30. nature of the functional loss. The protein which carries thyroid hormone and vitamin A, transthyretin,
  31. can produce nerve and brain amyloid disease, but it can also protect against other amyloid brain
  32. diseases; in Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, and the “prion diseases”
  33. (scrapie, kuru, CJD, BSE, etc.) amyloid particles are formed by different proteins. The transthyretin
  34. protein which is binding small molecules resists condensation into the amyloid fibrils, but without its
  35. normal vitamin A and thyroid hormone, it can create toxic fibrils. (Raghu, et al., 2002.)
  36. </p>
  37. <p>
  38. Around 1970 I read E. J. Field’s suggestion that aging tissues and tissues affected by viral diseases
  39. showed some similar structures (“inclusion bodies”) under the electron microscope. In following up those
  40. observations, it turned out that old tissues appeared to develop antigens “identical with, or similar
  41. to,” scrapie-infected young tissues. The premature aging caused by removal of the thymus gland in
  42. newborn animals produced similar results.
  43. </p>
  44. <p>
  45. Field’s group and others (e.g., Alpers) were clearly showing that the scrapie infection involved
  46. proteins, but not viruses with nucleic acids. In one of Field’s last publications (1978), he even
  47. suggested that the infectious process might depend on a structural rearrangement of the host’s
  48. molecules, similar to the idea which is now known as the “prion hypothesis.” Field’s suggestion was an
  49. important advance in the theory of aging, and the evidence supporting it is now voluminous, but that
  50. work has been omitted from the official histories.
  51. </p>
  52. <p>
  53. Although phenomena of “imprinting” and non-genetic inheritance had been established earlier, the
  54. dogmatism of genetics led the scientific establishment to reject everything that challenged the primacy
  55. of DNA. When I mentioned to my professors (in 1971) the evidence that scrapie was transmitted without
  56. nucleic acid, I could see from their reactions that it would be a very long time before much progress
  57. would be made in understanding the degenerative brain diseases. When the exact structure of the
  58. “infectious” protein was later worked out, and the 1997 Nobel Prize awarded (to Stanley Prusiner), I was
  59. surprised that no one from Field’s group was included. (In 1976, a nobel prize had been awarded to D.C.
  60. Gajdusek, for his promotion of the idea of “slow viruses” in general, and particularly for arguing that
  61. scrapie, CJD and kuru were caused by slow viruses.)
  62. </p>
  63. <p>
  64. In reading Prusiner’s autobiographical statements, I was even more surprised to see that he claimed to
  65. have been puzzled to find out, around 1983, that the infectious agent was a protein. I had thought that
  66. my professors were lethargic authoritarians when they refused to look at the evidence in 1970-72, but
  67. Prusiner’s expression of puzzlement so many years later over the absence of nucleic acid in the
  68. infectious agent is hard to account for.
  69. </p>
  70. <p>
  71. In my own research in 1971, I was interested in another kind of age-related “inclusion body,” which was
  72. variously called lipofuscin, age pigment, and ceroid pigment. This brown (yellow autofluorescent)
  73. pigment contained proteins and metals, as well as polyunsaturated lipids, and overlapped in many ways
  74. with the amyloid bodies. All of these inclusion bodies were known to be associated with radiation
  75. injury, aging, and hormonal-nutritional imbalances. Excess of estrogen, polyunsaturated fatty acids, and
  76. oxidative metals were major factors in the development of lipofuscin, and estrogen was also known to
  77. cause other types of “inclusion bodies” to develop in cells.
  78. </p>
  79. <p>
  80. Although very little was known about the composition of the inclusion bodies (they were usually thought
  81. to be organelles damaged by free radical activity, or antibodies resulting from autoimmunity), their
  82. involvement in aging and degenerative disease was clear<strong>,</strong> and it was widely known that
  83. ionizing radiation accelerated their formation. But it was just at this time that the national research
  84. priorities of the U.S. were redirected toward genetic explanations for all major diseases, with for
  85. example the “war on cancer” centering on the concepts of the “oncogene” and the cancer virus. Since the
  86. “slow virus” of cancer, or the viral oncogene, requires activation by something in the environment, its
  87. function is to distract the public’s attention from those environmental causes of disease, viz.,
  88. radiation and chemical pollution.
  89. </p>
  90. <p>
  91. The U.S. Public Health Service has historically been one of the branches of the military, and currently
  92. has 6000 commissioned officers. It has been intimately involved in all aspects of chemical, biological,
  93. and nuclear warfare, and it has participated in many covert projects, including experimentation on
  94. people without their knowledge. For decades, information on radiation injury to the public was hidden,
  95. classified, altered, or destroyed by the PHS. During the radiation disaster at Three Mile Island, they
  96. calmly defended the interests of the nuclear industry.
  97. </p>
  98. <p>
  99. After the April, 1986 catastrophe at the reactor in Chernobyl, some of the food being imported into the
  100. U.S. was so highly radioactive that the FDA secretly seized it, to prevent the public from being
  101. concerned. The first cow found to have BSE in England was in November, 1986, several months after
  102. England’s pastures had been heavily contaminated by rainfall carrying radioactive material from
  103. Chernobyl, which soaked into the soil and continued to contaminate crops for years (and will continue,
  104. for centuries). The number of sick cows increased rapidly to a peak in 1992. Human deaths from the
  105. similar disease (“variant CJD”) began a few years later.
  106. </p>
  107. <p>
  108. In June, 2000, a wildfire burned across southern Washington, turning the radioactive vegetation on the
  109. Hanford Nuclear Site into radioactive smoke, contaminating a wide area, including farms, dairies, and
  110. orchards. In 2003, the first cow in the U.S. with BSE was reported, from a dairy a few miles from the
  111. Hanford Site.
  112. </p>
  113. <p>
  114. Beginning in 1946, Bikini Island was used to test atomic bombs. In 1954, they began to test hydrogen
  115. bombs in the Pacific<strong>;</strong> some of the bombs were deliberately designed to vaporize whole
  116. islands, so that the effects of radioactive fallout could be studied. In 1954, the first child with kuru
  117. was reported in the rainy highlands of New Guinea.
  118. </p>
  119. <p>
  120. Within two years, hundreds of people in that area (of the Fore tribe) were dying from kuru, with the
  121. mortality highest among the women<strong>;</strong> in some villages, the majority of the women died
  122. from the disease, but by 1957 the mortality was falling rapidly. Between 1957 and 1964, 5% of the
  123. population of the Fore tribe died of the disease, according to D.C. Gajdusek, who had been sent by the
  124. U.S. Army to investigate the disease. Although Gajdusek graduated in 1946 from Harvard medical school as
  125. a pediatrician, in his autobiography he said that when he was drafted in 1951, the army assigned him to
  126. work in virology. In 1958, Gajdusek became director of the NIH laboratories for neurological and
  127. virological research. This was a remarkable achievement for someone who had supposedly only done some
  128. scattered field-work in infectious diseases, and whose purpose in going to New Guinea had been to study
  129. ''child growth and development in primitive cultures.'' The only published reason I have found that
  130. might be a basis for making him head of neurology, was his sending a diseased Fore brain to Fort Detrick
  131. in 1957.
  132. </p>
  133. <p>
  134. Gajdusek claimed to have seen the Fore people eating dead relatives, but his figures show that the
  135. disease was already in rapid decline when he arrived. He took photographs which were widely published in
  136. the US, supposedly showing cannibalism, but 30 years later, he said the photographs showed people eating
  137. pork, and that he had seen no cannibalism. (At the time Gajdusek was observing kuru in New Guinea, the
  138. influence of “cannibalism” on brain function was already in the news, because of the discovery by J.V.
  139. McConnell that the behavior of “trained” flatworms could be transmitted to other worms by chopping them
  140. up and feeding them to the naive worms.)
  141. </p>
  142. <p>
  143. Harvard medical school, in association with the military program centered at Fort Detrick,
  144. Fredericksburg, Maryland, was active in biological warfare in the 1940s, and I think it’s more plausible
  145. to see Gajdusek as a trouble-shooter for the biological warfare establishment, than as a biological
  146. researcher. One of his biographers has written that the idea of associating kuru with scrapie was
  147. suggested to him by a veterinarian, and that Gajdusek had responded by claiming to have experiments in
  148. progress to test that theory, four years before the experiments were actually made.
  149. </p>
  150. <p>
  151. In other words, the slow virus theory for which Gajdusek was given the Nobel Prize is scientific junk,
  152. which Gajdusek has repeatedly reinterpreted retrospectively, making it seem to have been anticipatory of
  153. the prion theory. Whatever actually caused kuru, I think the army was afraid that it was the result of
  154. radioactive fallout from one of its bomb tests, and that Gajdusek’s job was to explain it away.
  155. </p>
  156. <p>
  157. I suspect that kuru was the result of an unusual combination of malnutrition (the women were vegetarian)
  158. and radiation. In the very short time that Gajdusek spent in New Guinea, he claimed to have done studies
  159. to eliminate all of the alternative causes, nutritional, toxic, anthropological, bacterial causes,
  160. studies that would normally have required several years of well organized work. I don’t think he
  161. mentioned the possibility of radiation poisoning.
  162. </p>
  163. <p>
  164. In 1998 Congress commissioned a study of the health effects of radiation from bomb testing, and although
  165. the study examined the effects of only part of the bomb tests, it concluded that they had killed 15,000
  166. Americans. No one has tried to accurately estimate the numbers killed in other countries.
  167. </p>
  168. <p>
  169. Even very low doses of ionizing radiation create an inflammatory reaction (Vickers, et al., 1991), and
  170. there is evidence that the inflammatory state can persist as long as the individual lives<strong>;
  171. </strong>in Japan, the “acute phase” proteins are still elevated in the people who were exposed to
  172. radiation from the atomic bombs. The acute phase proteins that are increased by malnutrition and
  173. radiation increase the tendency to form amyloid deposits. Strong radiation can even cause, after a delay
  174. of more than a year, the development of vacuoles, which are the most obvious feature of the “prion”
  175. brain diseases. The persistent inflammatory reaction eventually produces cellular changes, but these
  176. were originally overlooked because of the theory that radiation is harmful only when it produces
  177. immediate changes in the DNA.
  178. </p>
  179. <p>
  180. Radiation damage to the brain is most visible early in life, and in old age. In 1955, Alice Stewart
  181. showed that prenatal x-rays increase the incidence of brain cancer, leukemia, and other cancers. In
  182. 1967, a study in Japanese bomb survivors found that prenatal exposure to radiation had reduced their
  183. head size and brain size. In 1979, Sternglass and Bell showed extremely close correspondence between
  184. scores on the SAT and prenatal exposure to radiation.
  185. </p>
  186. <p>
  187. Serum amyloid A, which can increase 1000-fold under the influence of proinflammatory cytokines,
  188. resulting from irradiation, stress, trauma, or infection, is an activator of phospholipase A2 (PLA2),
  189. which releases fatty acids. Some of the neurodegenerative states, including amyloid-prion diseases,
  190. involve activated PLA2, as well as increases in the toxic breakdown products of the polyunsaturated
  191. fatty acids, such as 4-hydroxynonenal. The quantity of PUFA in the tissues strongly determines the
  192. susceptibility of the tissue to injury by radiation and other stresses. But a diet rich in PUFA will
  193. produce brain damage even without exceptional stressors, when there aren’t enough antioxidants, such as
  194. vitamin E and selenium, in the diet.
  195. </p>
  196. <p>
  197. Amyloidosis has traditionally been thought of as a condition involving deposits mainly in blood vessels,
  198. kidneys, joints and skin and in extracellular spaces in the brain, and the fact that the “amyloid”
  199. stained in a certain way led to the idea that it was a single protein. But as more proteins--currently
  200. about 20--were identified in amyloid deposits, it was gradually realized that the deposits can be
  201. identified inside cells of many different tissues, before the larger, very visible, extracellular
  202. deposits are formed.
  203. </p>
  204. <p>
  205. There is evidence of a steady increase in the death rate from amyloidosis. It kills women at a younger
  206. age than men, often at the age of 50 or 60.
  207. </p>
  208. <p>
  209. Serum amyloid P is called “the female protein” in hamsters, because of its association with
  210. estrogen<strong>;</strong> castrated (or estrogen treated) males also produce large amounts of it, and
  211. its excess is associated with the deposition of amyloid (Coe and Ross, 1985). It can bind other amyloid
  212. proteins together, accelerating the formation of fibrils, but this function is probably just a variation
  213. of a normal function in immunity, tissue repair, and development.
  214. </p>
  215. <p>
  216. Estrogen increases the inflammation-associated substances such as IL-6, C-reactive protein, and amyloid,
  217. and liberates fatty acids, especially the unstable polyunsaturated fatty acids. It also increases
  218. fibrinogen and decreases albumin, increasing the leakiness of capillaries. The decrease of albumin
  219. increases the concentration of free fatty acids and tryptophan, which would normally be bound to
  220. albumin.
  221. </p>
  222. <p>
  223. In the U.S. and Europe, livestock are fed large amounts of high-protein feeds, and currently these
  224. typically contain fish meal and soybeans. The estrogenic materials in soybeans increase the animals’
  225. tendency toward inflammation (with increased serum amyloid).
  226. </p>
  227. <p>
  228. Officially, BSE appeared because cows were fed slaughter-house waste containing tissues of sheep that
  229. had died of scrapie. Scrapie was a nerve disease of sheep, first reported in Iceland in the 18th
  230. century. When I was studying the digestive system and nutrition of horses, I learned that it was common
  231. for horses in Norway to be fed dried fish during the winter. This abundant food was probably used for
  232. sheep, as well as for horses. The extra protein provided by fish meal is still important for sheep in
  233. areas where pastures are limited, but it has now become common to use it to increase productivity and
  234. growth throughout the lamb, beef, and dairy industries, as well as in most lab chows fed to experimental
  235. animals, such as the hamsters used for testing the infectivity of the diseased tissues.
  236. </p>
  237. <p>
  238. Increased dietary polyunsaturated fatty acids (PUFA) suppress the activity of the ruminal bacteria which
  239. are responsible for the hydrogenation-detoxication of PUFA in the animal’s diet. This allows the
  240. unstable fats, 98% of which are normally destroyed, to pass into the animals’ tissues and milk.
  241. </p>
  242. <p>
  243. The polyunsaturated fats in fish are very unstable, and when they get past the bacterial saturases
  244. (biohydrogenases) in the rumen that normally protect ruminants from lipid peroxidation, they are likely
  245. to cause their toxic effects more quickly than in humans, whose antioxidant systems are highly
  246. developed. The toxic effects of polyunsaturated fats involve altered (immunogenic) protein structure,
  247. decreased energy metabolism, and many inflammatory effects produced by the prostaglandin-like
  248. substances. Marine fish are now so generally polluted with dioxin, that in Japan there is a clear
  249. association between the amount of fish in a person’s diet (their body content of EPA and DHA) and the
  250. amount of dioxin in their body.
  251. </p>
  252. <p>
  253. Radiation and many kinds of poisoning cause early peroxidation of those highly unsaturated fats, and the
  254. breakdown products accelerate the changes in the folding and chelating behavior of proteins. The
  255. accumulation of altered proteins is associated with the degenerative diseases. The role of toxic metals
  256. in brain inflammation is well established (e.g., aluminum, lead, mercury<strong>: </strong>Campbell, et
  257. al., 2004<strong>; </strong>Dave, et al., 1994<strong>; </strong>Ronnback and Hansson, 1992<strong
  258. >)</strong>.
  259. </p>
  260. <p>
  261. The “prion hypothesis” has the value of weakening the fanaticism of the DNA-genetics doctrine, but it
  262. has some problems. There are now several examples in which other degenerative diseases have been
  263. transmitted by procedures similar to those used to test the scrapie agent. (e.g., Goudsmit, et al.,
  264. 1980; Xing, et al., 2001; Cui, et al., 2002.) Experimental controls haven’t been adequate to distinguish
  265. between the pure prion and its associated impurities. Gajdusek burned a sample of the infective hamster
  266. brain to ash, and found that it still retained “infectivity.” He argued that there was a mineral
  267. template that transmitted the toxic conformation to normal proteins. Others have demonstrated that the
  268. active structure of the infective agent is maintained by a carbohydrate scaffolding, or that the
  269. infectivity is destroyed by the frequency of ultraviolet light that destroys the active lipid of
  270. bacterial endotoxin, lipopolysaccharide.
  271. </p>
  272. <p>
  273. But simply injuring the brain or other organ (by injecting anything) will sometimes activate a series of
  274. reactions similar to those seen in aging and the amyloidoses. When a slight trauma leads to a prolonged
  275. or expanding disturbance of structure and function, the process isn’t essentially different from
  276. transmitting a condition to another individual. The problem is being “transmitted” from the initial
  277. injury, recruiting new cells, and passing the disturbed state on to daughter cells in a disturbed form
  278. of regeneration. Keloids, hypertrophic scars, are analogous to the dementias in their overgrowth of
  279. connective tissue cells<strong>:</strong> In the aging or injured brain, the glial cells (mainly
  280. astrocytes) proliferate, in reparative processes that sometimes become exaggerated and harmful.
  281. </p>
  282. <p>
  283. When tissue phospholipids contain large amounts of polyunsaturated fatty acids, large amounts of
  284. prostaglandins are immediately formed by any injury, including low doses of ionizing radiation. The
  285. liberated free fatty acids have many other effects, including the formation of highly reactive
  286. aldehydes, which modify DNA, proteins, and other cell components.
  287. </p>
  288. <p>
  289. Animals which are “deficient” in the polyunsaturated fatty acids have a great resistance to a variety of
  290. inflammatory challenges. Their tissues appear to be poor allergens or antigens, since they can be easily
  291. grafted onto other animals without rejection. Something related to this can probably be seen in the data
  292. of human liver transplants. Women’s livers are subjected to more lipid peroxidation than men’s, because
  293. of the effects of estrogen (increasing growth hormone and free fatty acids, and selectively mobilizing
  294. the polyunsaturated fatty acids and increasing their oxidation). Liver transplants from middle-aged
  295. female donors fail much more often (40 to 45%) than livers from male donors (22 to 25%), and other
  296. organs show the same effect. The autoimmune diseases are several times as common in women as in men,
  297. suggesting that some tissues become relatively incompatible with their own body, after prolonged
  298. exposure to the unstable fatty acids. If we consider the healthy function of the immune system to be the
  299. removal or correction of injured tissue, it’s reasonable to view the random interactions of oxidized
  300. fats with proteins as exactly the sort of thing our immune system takes care of.
  301. </p>
  302. <p>
  303. The serum amyloids A and P and the closely related lipoproteins are considered to be important parts of
  304. our “innate immunity,” operating in a more general way than the familiar system of specific acquired
  305. immunities.
  306. </p>
  307. <p>
  308. The amyloids and lipoproteins are powerfully responsive to bacterial endotoxin, LPS, and their
  309. structural feature that binds it, the “pleated sheet” structure, appears to also be what allows the
  310. amyloids to form amorphous deposits and fibrils under some circumstances. Our innate immune system is
  311. perfectly competent for handling our normal stress-induced exposures to bacterial endotoxin, but as we
  312. accumulate the unstable fats, each exposure to endotoxin creates additional inflammatory stress by
  313. liberating stored fats. The brain has a very high concentration of complex fats, and is highly
  314. susceptible to the effects of lipid peroxidative stress, which become progressively worse as the
  315. unstable fats accumulate during aging.
  316. </p>
  317. <p>
  318. More than 60 years ago, a vitamin E deficiency was known to cause a brain disease, sometimes associated
  319. with sterility and muscular dystrophy. The symptoms of the brain disease were similar to those of “mad
  320. cow disease,” and the condition is now usually called “crazy chick disease.” Veterinarians are usually
  321. taught that it is caused by a selenium deficiency, but it is actually the result of an excess of PUFA in
  322. the diet, and is exacerbated by increased iron or other oxidants, and prevented by increased vitamin E,
  323. selenium, or substitution of saturated fats for the unsaturated.
  324. </p>
  325. <p>
  326. Terminology, established by tradition and thoughtless memorization, obscures many of the commonalities
  327. in the various brain diseases. Brain inflammation (Betmouni and Perry, 1999; Perry, et al., 1998),
  328. myelination disorders, edema, overgrowth of the astroglia, and circulatory changes are common
  329. occurrences in most of the degenerative encephalopathies, but traditional textbook descriptions have
  330. created the impression that each disease is pathologically very distinct from the others. The current
  331. classification of “the prion diseases” is reifying a group of symptoms that aren’t specific to any
  332. specific known cause. And standard laboratory procedures for preparing brain sections for microscopic
  333. examination may cause brain cells to shrink to 5% of their original volume (Hillman and Jarman, <strong
  334. ><em>Atlas of the cellular structure of the human nervous system,</em></strong> 1991), so the
  335. objectivity of pathological studies shouldn’t be over-estimated.
  336. </p>
  337. <p>
  338. According to a 1989 study (Laura Manuelidis, neuropathology department at Yale), 13% of the people who
  339. had died from “Alzheimer’s disease” actually had CJD. Between 1979 and 2000, the number of people dying
  340. annually from Alzheimer’s disease increased 50-fold. Very competent neuropathologists differ radically
  341. in their descriptions of the dementia epidemic.
  342. </p>
  343. <p>
  344. By some tests, the “prion” resembles the LPS endotoxin. One of the interesting developments of the prion
  345. theory is that a particular structure that appears when the prion becomes toxic, the “beta pleated
  346. sheet,” is also a feature of most of the normal proteins that can form amyloid, and that this structure
  347. is directly related to binding and eliminating the bacterial LPS. If the prion theory is correct about
  348. the conversion of a normal protein into the pleated sheet, it isn’t necessarily correct about the
  349. incurability of the condition. The innate immune system should be able to inactivate the prion just as
  350. it does the bacterial endotoxin, if we remove the conditions that cause the innate immune reaction to
  351. amplify the inflammation beyond control.
  352. </p>
  353. <p>
  354. In the prion diseases, the severely damaged brain appears to have a “pathological overactivity” of the
  355. serotonergic systems (Fraser, et al., 2003). This is an interesting parallel to Alzheimer’s disease,
  356. since it has been known for several years that the blood platelets have an increased tendency to release
  357. serotonin in that more common form of dementia. Serotonin itself is toxic to nerves, and is part of the
  358. adaptive system that gets out of control during prolonged inflammation. Serotonin is an important
  359. activator of the phospholipases.
  360. </p>
  361. <p>
  362. The modification of proteins’ structure by glycosylation is involved in the development of the toxic
  363. form of the “prionic” protein, as well as in all the degenerative processes of aging. Until the ability
  364. to use sugar is impaired, cells produce enough carbon dioxide to protect proteins against random
  365. glycation, but with each exposure to free polyunsaturated fatty acids, the ability to use glucose is
  366. damaged. In the dementias, the brain has a greatly reduced ability to use glucose.
  367. </p>
  368. <p>
  369. One of estrogen’s central effects is to shift metabolism away from the oxidation of glucose, decreasing
  370. carbon dioxide production. There is a much higher incidence of Alzheimer’s disease in women, and
  371. estrogen exposure exacerbates all of the changes that lead to it, such as shifts in nerve transmitters,
  372. increased vascular leakiness, and the increased production of the acute phase proteins.
  373. </p>
  374. <p>
  375. Everything that is known about the “always fatal” prionic diseases, the diseases of disturbed protein
  376. folding, suggests that they can be avoided and even reversed by systematically reversing the processes
  377. that amplify inflammation.
  378. </p>
  379. <p>
  380. People who take aspirin, drink coffee, and use tobacco, have a much lower incidence of Alzheimer’s
  381. disease than people who don’t use those things. Caffeine inhibits brain phospholipase, making it
  382. neuroprotective in a wide spectrum of conditions. In recent tests, aspirin has been found to prevent the
  383. misfolding of the prion protein, and even to reverse the misfolded beta sheet conformation, restoring it
  384. to the harmless normal conformation. Nicotine might have a similar effect, preventing deposition of
  385. amyloid fibrils and disrupting those already formed (Ono, et al., 2002). Vitamin E, aspirin,
  386. progesterone, and nicotine also inhibit phospholipase, which contributes to their antiinflammatory
  387. action. Each of the amyloid-forming proteins probably has molecules that interfere with its toxic
  388. accumulation.
  389. </p>
  390. <p>
  391. Thyroid hormone, vitamins A and E, niacinamide (to inhibit systemic lipolysis), magnesium, calcium,
  392. progesterone, sugar, saturated fats, and gelatin all contribute in basic ways to prevention of the
  393. inflammatory states that eventually lead to the amyloid diseases. The scarcity of degenerative brain
  394. disease in high altitude populations is consistent with a protective role for carbon dioxide.
  395. </p>
  396. <p>
  397. The relatively sudden acceptability of the idea of non-genetic transmission doesn't mean that Lamarck
  398. has been rehabilitated by the scientific establishment; it could just be that it's the most politically
  399. acceptable way to explain the outbreaks of deadly disease caused by the industrialization of foods and
  400. the exposure of the population to dangerous levels of radiation.
  401. </p>
  402. <p>&nbsp;</p>
  403. <p><h3>REFERENCES</h3></p>
  404. <p>
  405. J Autoimmun. 1989 Aug;2(4):543-52. <strong>Estrogen induces the development of autoantibodies and
  406. promotes salivary gland lymphoid infiltrates in normal mice.</strong> Ahmed SA, Aufdemorte TB, Chen
  407. JR, Montoya AI, Olive D, Talal N. “We hypothesize that an imbalance of the in utero sex hormone
  408. microenvironment critically influences the<strong>
  409. fetal immune system. We have termed this influence immunological imprinting. After birth this
  410. imprinting could contribute to immune-mediated disorders. To test this hypothesis, we developed a
  411. mouse model in which normal mice were</strong> prenatally exposed to estrogens. In preliminary
  412. experiments, these mice produced higher numbers of APFC to Br-ME, particularly in the peritoneal cavity
  413. cell exudates. Furthermore, mice prenatally exposed to <strong>estrogens had accelerated development of
  414. autoimmune salivary gland lesions indistinguishable from Sjogren's syndrome
  415. </strong>(SS) in humans.”
  416. </p>
  417. <p>
  418. J Gen Virol. 1978 Dec;41(3):503-16. <strong>The scrapie agent: evidence against its dependence for
  419. replication on intrinsic nucleic acid.</strong> Alper T, Haig DA, Clarke MC. Exposure of the scrapie
  420. agent to u.v. light at various wavelengths has shown<strong>
  421. that light of 237 nm is 4 to 5 times as effective in inactivating it as 'germicidal' wavelengths
  422. (250 to 270 nm); whereas with systems that depend on</strong> RNA or DNA for function, inactivation
  423. is most effective by wavelengths in the germicidal range and there is a minimum of response in the
  424. wavelength region round 240 nm. The action spectrum for the scrapie agent is reminiscent of the
  425. absorption spectrum for purified bacterial endotoxin, identified as a lipopolysaccharide complex.
  426. </p>
  427. <p>
  428. Am J Pathol. 1971 Oct; 65(1): 43-50. <strong>Disseminated amyloidosis in germfree mice. Spontaneous
  429. prevalence, relationship to ionizing radiation and pathogenetic implications.</strong> Anderson RE.
  430. </p>
  431. <p>
  432. Neurobiol Dis. 2002 Dec; 11(3): 386-93. <strong>Astrocytes accumulate 4-hydroxynonenal adducts in murine
  433. scrapie and human Creutzfeldt-Jakob disease.</strong> Andreoletti O, Levavasseur E, Uro-Coste E,
  434. Tabouret G, Sarradin P, Delisle MB, Berthon P, Salvayre R, Schelcher F, Negre-Salvayre A.
  435. </p>
  436. <p>
  437. Biol Chem. 1999 Nov;380(11):1295-306. <strong>Prion rods contain an inert polysaccharide
  438. scaffold.</strong> Appel TR, Dumpitak C, Matthiesen U, Riesner D. “<strong>Only glucose was obtained
  439. by acid hydrolysis of the remnant and methylation analysis showed 80% 1,4-, 15% 1,6- and 5%
  440. 1,4,6-linked glucose units. The physical and chemical properties as well as the absence of terminal
  441. glucose units indicate a very high molecular mass of the polysaccharide. No evidence was found for
  442. covalent bonds between PrP and the polysaccharide. The polysaccharide certainly contributes to the
  443. unusual chemical and physical stability of prion rods, acting like a scaffold.</strong>”
  444. </p>
  445. <p>
  446. Arch Neurol. 1974 Sep; 31(3): 174-82. <strong>Altered cell membranes in Creutzfeldt-Jakob
  447. disease.</strong> Microchemical studies. Bass NH, Hess HH, Pope A.
  448. </p>
  449. <p>
  450. Neuropathol Appl Neurobiol. <strong> 1999</strong> Feb;25(1):20-8. <strong>The acute inflammatory
  451. response in CNS following injection of prion brain homogenate or normal brain homogenate.</strong>
  452. Betmouni S, Perry VH. “The neuropathological hallmarks of end-stage prion disease are vacuolation,
  453. neuronal loss, astrocytosis and deposition of PrPSc amyloid. We have also shown that there is an
  454. inflammatory response in the brains of scrapie-affected mice from 8 weeks post-injection.” <strong>“The
  455. well circumscribed inflammatory response seen previously at 8 weeks is therefore a consequence of a
  456. disease process rather than a surgical artefact. This disease process may be related to a localized
  457. accumulation of PrPSc sufficient to stimulate an inflammatory response which in turn may contribute
  458. to neuronal loss.”</strong>
  459. </p>
  460. <p>
  461. Neuropathol Appl Neurobiol. 1999 Feb; 25(1): 20-8. <strong>The acute inflammatory response in CNS
  462. following injection of prion brain homogenate or normal brain homogenate.</strong> Betmouni S, Perry
  463. VH.
  464. </p>
  465. <p>
  466. Curr Biol. 1999 Sep 23;9(18):R677-9. <strong>Vacuolation in murine prion disease: an informative
  467. artifact.</strong> Betmouni S, Clements J, Perry VH.
  468. </p>
  469. <p>
  470. Neuroscience. 1996 Sep; 74(1): 1-5. <strong>Evidence for an early inflammatory response in the central
  471. nervous system of mice with scrapie.</strong> Betmouni S, Perry VH, Gordon JL.
  472. </p>
  473. <p>
  474. Ann N Y Acad Sci 1982;396:131-43. <strong>Alzheimer's disease and transmissible virus dementia
  475. (Creutzfeldt-Jakob disease).</strong> Brown P, Salazar AM, Gibbs CJ Jr, Gajdusek DC.
  476. </p>
  477. <p>
  478. Neuroscience. 1996 Sep;74(1):1-5. <strong>Evidence for an early inflammatory response in the central
  479. nervous system of mice with scrapie.</strong> Betmouni S, Perry VH, Gordon JL. “In Alzheimer's
  480. disease, the most prevalent of the neurodegenerative diseases, inflammation of the CNS contributes to
  481. the pathology and is a target for therapy. In contrast, the group of neurodegenerative conditions known
  482. as the Prion Diseases have been widely reported as lacking any inflammatory elements despite the many
  483. similarities between the pathologies of Alzheimer's Disease and Prion Diseases We have found evidence
  484. for an inflammatory component in mouse scrapie, characterized by microglial activation and T-lymphocyte
  485. recruitment, which appears long before any clinical signs of the disease and spreads along well-defined
  486. anatomical pathways.”
  487. </p>
  488. <p>
  489. Nat Med. 1999 Jun;5(6):694-7. <strong>Serum amyloid P component controls chromatin degradation and
  490. prevents antinuclear autoimmunity.</strong> Bickerstaff MC, Botto M, Hutchinson WL, Herbert J,
  491. Tennent GA, Bybee A, Mitchell DA, Cook HT, Butler PJ, Walport MJ, Pepys MB. “Serum amyloid P component
  492. (SAP)<strong> . . .</strong> is the single normal circulating protein that shows specific
  493. calcium-dependent binding to DNA and chromatin in physiological conditions. The avid binding of SAP
  494. displaces H1-type histones and thereby solubilizes native long chromatin, which is otherwise profoundly
  495. insoluble at the physiological ionic strength of extracellular fluids.” “Here we show that mice with
  496. targeted deletion of the SAP gene spontaneously develop antinuclear autoimmunity and severe
  497. glomerulonephritis, a phenotype resembling human systemic lupus erythematosus, a serious autoimmune
  498. disease.” “These findings indicate that SAP has an important physiological role, inhibiting the
  499. formation of pathogenic autoantibodies against chromatin and DNA, probably by binding to chromatin and
  500. regulating its degradation.”
  501. </p>
  502. <p>
  503. J Neurosci Res. 2004 Feb 15;75(4):565-72. <strong>Chronic exposure to aluminum in drinking water
  504. increases inflammatory parameters selectively in the brain.</strong> Campbell A, Becaria A, Lahiri
  505. DK, Sharman K, Bondy SC.
  506. </p>
  507. <p>
  508. Mutat Res. 2001 Mar; 488(1): 39-64. <strong>Mutation processes at the protein level: is Lamarck
  509. back?</strong> Chernoff YO. <strong>“The experimental evidence accumulated for the last half of the
  510. century clearly suggests that inherited variation is not restricted to the changes in genomic
  511. sequences.</strong> The prion model, originally based on unusual transmission of certain
  512. neurodegenerative diseases in mammals, provides a molecular mechanism for the template-like reproduction
  513. of alternative protein conformations. <strong>Recent data extend this model to protein-based genetic
  514. elements in yeast and other fungi</strong>.” “Prion-forming abilities appear to be conserved in
  515. evolution, despite the divergence of the corresponding amino acid sequences. Moreover, a wide variety of
  516. proteins of different origins appear to possess the ability to form amyloid-like aggregates, that in
  517. certain conditions might potentially result in prion-like switches. <strong>This suggests a possible
  518. mechanism for the inheritance of acquired traits,</strong> postulated in the Lamarckian theory of
  519. evolution.” J Clin Invest. 1985 Jul;76(1):66-74.<strong>
  520. Hamster female protein, a sex-limited pentraxin, is a constituent of Syrian hamster amyloid.</strong
  521. > Coe JE, Ross MJ.
  522. </p>
  523. <p>
  524. Pathol Int. 2002 Jan; 52(1): 40-5. <strong>Acceleration of murine AA amyloidosis by oral administration
  525. of amyloid fibrils extracted from different species.</strong> Cui D, Kawano H, Takahashi M, Hoshii
  526. Y, Setoguchi M, Gondo T, Ishihara T. “We herein report that experimental murine amyloid A (AA)
  527. deposition is accelerated by oral administration of semipurified amyloid fibrils extracted from
  528. different species. Three groups of mice were treated with semipurified murine AA amyloid fibrils,
  529. semipurified bovine AA amyloid fibrils or semipurified human light chain-derived (A(lambda)) amyloid
  530. fibrils for 10 days. After 3 weeks, each mouse was subjected to inflammatory stimulation by subcutaneous
  531. injection with a mixture of complete Freund's adjuvant supplemented with Mycobacterium butyricum.”
  532. “Amyloid deposits were detected in 14 out of 15 mice treated with murine AA amyloid fibrils, 12 out of
  533. 15 mice treated with bovine AA amyloid fibrils and 11 out of 15 mice treated with human A(lambda)
  534. amyloid fibrils. No amyloid deposits were detected in control mice receiving the inflammatory stimulant
  535. alone or in amyloid fibril-treated mice without inflammatory stimulation. Our results suggest that AA
  536. amyloid deposition<strong>
  537. is accelerated by oral administration of semipurified amyloid fibrils when there is a concurrent
  538. inflammatory stimulation.”
  539. </strong>
  540. </p>
  541. <p>
  542. Br J Pharmacol. 2003 Apr;138(7):1207-9. <strong>Neuroprotection by caffeine and adenosine A2A receptor
  543. blockade of beta-amyloid neurotoxicity.</strong> Dall'lgna OP, Porciuncula LO, Souza DO, Cunha RA,
  544. Lara DR. “This constitutes the first in vitro evidence to suggest that adenosine A(2A) receptors may be
  545. the molecular target responsible for the <strong>observed beneficial effects of caffeine consumption in
  546. the development of Alzheimer's disease.</strong>”<strong></strong>
  547. </p>
  548. <p>
  549. Biochemistry. 2003 Nov 25; 42(46): 13667-72. <strong>Insertion of externally administered amyloid beta
  550. peptide 25-35 and perturbation of lipid bilayers.</strong> Dante S, Hauss T, Dencher NA. “For a very
  551. long time, the aggregated form of the Abeta was supposed to be responsible for the neurodegeneration
  552. that occurs in AD. Recently, the attention has been diverted to the monomeric or oligomeric forms of
  553. Abeta and their interaction with cellular targets.”
  554. </p>
  555. <p>
  556. Dev Neurosci. 1994;16(3-4):222-31. <strong>Astrocytes as mediators of methylmercury neurotoxicity:
  557. effects on D-aspartate and serotonin uptake.</strong> Dave V, Mullaney KJ, Goderie S, Kimelberg HK,
  558. Aschner M.
  559. </p>
  560. <p>
  561. Adv Exp Med Biol. 1989; 266: 259-70; discussion 271. <strong>Phospholipases and the molecular basis for
  562. the formation of ceroid in Batten Disease.</strong> Dawson G, Dawson SA, Siakotos AN. “Lysosomal
  563. ceroid/lipofuscinosis storage in human, canine, and ovine forms of neuronal ceroidlipofuscinosis is
  564. predominantly in neurons and retinal pigment epithelial cells. Despite problems in identifying
  565. individual storage materials, it is believed that non-enzymic oxidation of unsaturated fatty acids in
  566. phospholipids and inhibition of lysosomal proteolysis, leading to massive deposition of autofluorescent
  567. pigment, is the cause of the disease.” <strong>“We believe that the PLA1 deficiency leads to transient
  568. lysosomal storage of phospholipids containing peroxy fatty acids which are then chemically converted
  569. to hydroxynonenal, a potent inhibitor of a thiol-dependent enzymes.</strong> Inhibition of proteases
  570. is believed to be intrinsic to the formation of lipofuscin.”
  571. </p>
  572. <p>
  573. Ann Rheum Dis. 2001 Jul;60(7):694-5. <strong>Concomitant diagnosis of primary Sjogren's syndrome and
  574. systemic AL amyloidosis.</strong> Delevaux I, Andre M, Amoura Z, Kemeny JL, Piette JC, Aumaitre O.
  575. </p>
  576. <p>
  577. Mol Biol Rep. 1996;23(3-4):253-60. <strong>The interaction of C-reactive protein and serum amyloid P
  578. component with nuclear antigens.
  579. </strong>Du Clos TW. “The pentraxins are a family of proteins characterized by cyclic pentameric
  580. structure, calcium-dependent ligand binding and sequence homology. The two main representatives of this
  581. family are the serum proteins, C-reactive protein (CRP) and serum amyloid P component (SAP). In man CRP
  582. is an acute phase reactant which increases up to 1,000 fold during the acute phase<strong></strong
  583. >response whereas SAP is a constitutive protein expressed at about 30 micrograms/ml. These proteins
  584. activate complement through the classical pathway and participate in opsonization of particulate
  585. antigens<strong></strong>and bacteria. In the past several years it has been determined that both of
  586. these pentraxins interact with nuclear antigens including chromatin and small nuclear ribonucleoproteins
  587. (snRNPs). Both CRP and SAP have nuclear transport signals which facilitate their entry into the nuclei
  588. of intact cells. Furthermore, these pentraxins have been shown to affect the clearance of nuclear
  589. antigens in vivo.”
  590. </p>
  591. <p>
  592. Am J Pathol. 1996 Oct;149(4):1313-20. <strong>Lipoproteins accumulate in immune deposits and are
  593. modified by lipid peroxidation in passive Heymann nephritis.</strong> Exner M, Susani M, Witztum JL,
  594. Hovorka A, Curtiss LK, Spitzauer S, Kerjaschki D.
  595. </p>
  596. <p>
  597. J Med Genet. 1976 Dec;13(6):479-95.<strong>
  598. Scrapie: a review of its relation to human disease and ageing.</strong> Field EJ.
  599. </p>
  600. <p>
  601. Age Ageing. 1978 Feb;7(1):28-39. <strong>Immunological assessment of ageing: emergence of scrapie-like
  602. antigens.</strong> Field EJ.
  603. </p>
  604. <p>
  605. Acta Neurol Scand. 1975 Apr;51(4):299-309. <strong>Cellular sensitization in kuru, Jakob-Creutzfeldt
  606. disease and multiple sclerosis: with a note on the biohazards of slow infection work.</strong> Field
  607. EJ, Shenton BK.
  608. </p>
  609. <p>
  610. Brain. 1973 Sep;96(3):629-36. <strong>Altered response to scrapie tissues in neurological disease.
  611. Possible evidence for an antigen associated with reactive astrocytes.</strong> Field EJ, Shenton BK.
  612. </p>
  613. <p>
  614. Nature. 1973 Jul 20;244(5412):174-6. <strong>Scrapie-like antigen(s) in ageing tissues.</strong> Field
  615. EJ, Shenton BK.
  616. </p>
  617. <p>
  618. Nature. 1973 Jul 13;244(5411):96-7. <strong>Rapid immunological method for diagnosis of natural scrapie
  619. in sheep.</strong> Field EJ, Shenton BK.
  620. </p>
  621. <p>
  622. Gerontologia. 1973;19(4):203-10.<strong>
  623. Thymectomy and immunological ageing in mice: precocious emergence of scrapie-like antigen.</strong>
  624. Field EJ, Shenton BK.
  625. </p>
  626. <p>
  627. Gerontologia. 1973;19(4):211-9. <strong>Emergence of new antigens in ageing tissues.</strong> Field EJ,
  628. Shenton BK.
  629. </p>
  630. <p>
  631. Nature. 1972 Nov 10;240(5376):104-6. <strong>Rapid diagnosis of scrapie in the mouse.</strong> Field EJ,
  632. Shenton BK.
  633. </p>
  634. <p>
  635. J Neurol Sci. 1972 Nov;17(3):347-64. <strong>An electron-microscopic study of scrapie in the rat:
  636. further observations on "inclusion bodies" and virus-like particles.</strong> Field EJ, Narang HK.
  637. </p>
  638. <p>
  639. Lancet. 1970 Oct 10;2(7676):780-1. <strong>Amyloidosis, Alzheimer's disease, and ageing.</strong> Field
  640. EJ.
  641. </p>
  642. <p>
  643. Nature. 1970 Jun 6;226(249):971-3. <strong>Evidence against transmission of scrapie by animal house
  644. fomites.</strong> Field EJ, Joyce G.
  645. </p>
  646. <p>
  647. Arch Gesamte Virusforsch. 1970;30(2):224-37. <strong>The incorporation of (3H) thymidine and (14C)
  648. glucosamine into a DNA-polysaccharide complex in normal and scrapie-affected mouse brain.</strong>
  649. Adams DH, Caspary EA, Field EJ.
  650. </p>
  651. <p>
  652. Biochem J. 1969 Sep;114(2):19P-20P. <strong> Structural changes in scrapie affected brain.</strong>
  653. Field EJ, Peat A.
  654. </p>
  655. <p>
  656. J Gen Virol. 1969 Jul;5(1):149-50. <strong>Failure of interferon to modify scrapie in the mouse.</strong
  657. > Field EJ, Joyce G, Keith A.
  658. </p>
  659. <p>
  660. Nature. 1969 Apr 5;221(188):90-1. <strong>Susceptibility of scrapie agent to ionizing radiation.</strong
  661. > Field EJ, Farmer F, Caspary EA, Joyce G.
  662. </p>
  663. <p>
  664. Nature. 1969 Mar 29;221(187):1265-6.<strong>
  665. Neurological illness after inoculation of tissue from tumour bearing animals.</strong> Field EJ,
  666. Adams DH, Joyce G.
  667. </p>
  668. <p>Lancet. 1968 May 4;1(7549):981-2. <strong>Transmission of kuru to mice.</strong> Field EJ.</p>
  669. <p>
  670. Br J Exp Pathol. 1967 Dec;48(6):662-4. <strong>Invasion of the mouse nervous system by scrapie
  671. agent.</strong> Field EJ.
  672. </p>
  673. <p>
  674. Acta Neuropathol (Berl). 1967 Nov 29;9(4):305-15. <strong>Scrapie in the rat: an electron-microscopic
  675. study. II. Glial inclusions.</strong> Field EJ, Raine CS, Joyce G.
  676. </p>
  677. <p>
  678. J Neurosci. 2001 Jan 1;21(1):136-42.<strong>
  679. Vaccination for neuroprotection in the mouse optic nerve: implications for optic
  680. Neuropathies.</strong> Fisher J, Levkovitch-Verbin H, Schori H, Yoles E, Butovsky O, Kaye JF,
  681. Ben-Nun A, Schwartz M. “<strong>T-cell autoimmunity to myelin basic protein was recently shown to be
  682. neuroprotective in injured rat optic nerves.</strong>” “The results of this study show that survival
  683. of RGCs after axonal injury can be<strong>
  684. enhanced by vaccination with an appropriate self-antigen.</strong> Furthermore, the use of
  685. nonencephalitogenic myelin peptides for immunization apparently allows neuroprotection without incurring
  686. the risk of an autoimmune disease.”
  687. </p>
  688. <p>
  689. Neuropathol Appl Neurobiol. 2003 Oct;29(5):482-95. <strong>Neuronal and astrocytic responses involving
  690. the serotonergic system in human spongiform encephalopathies.</strong> Fraser E, McDonagh AM, Head
  691. M, Bishop M, Ironside JW, Mann DM.
  692. </p>
  693. <p>
  694. J Neural Transm. 2001;108(2):221-30. <strong>Difference in toxicity of beta-amyloid peptide with aging
  695. in relation to nerve growth factor content in rat brain.</strong> Fukuta T, Nitta A, Itoh A,
  696. Furukawa S, Nabeshima T. “NGF levels in the hippocampus were<strong>
  697. increased only in adult rats. These results suggest that Abeta is toxic only in the matured adult
  698. brain, and that the mechanism of toxicity is related to NGF synthesis.”</strong>
  699. </p>
  700. <p>
  701. Science 197: 943-960(1977). <strong>Unconventional viruses and the origin and disappearance of
  702. kuru.</strong> Gajdusek, D.C.
  703. </p>
  704. <p>
  705. Trends Mol Med. 2001 Aug;7(8):336. <strong>Beneficial autoimmunity in traumatic brain injury.</strong>
  706. Gurwitz D.
  707. </p>
  708. <p>
  709. BMJ 2004; 328 :19, <strong>Effect of low doses of ionising radiation in infancy on cognitive function in
  710. adulthood: Swedish population based cohort study.</strong> Hall P, Adami HO, Trichopoulos D et al.
  711. </p>
  712. <p>
  713. Arch Pathol. 1966 Oct; 82(4): 353-5.<strong>
  714. A lipofuscin-like pigment in the kidneys of estrogen-treated rats.</strong> Harris C.
  715. </p>
  716. <p>
  717. Int J Radiat Biol. 2003 Feb; 79(2): 129-36<strong>. Radiation dose-dependent increases in inflammatory
  718. response markers in A-bomb Survivors.</strong> Hayashi T, Kusunoki Y, Hakoda M, Morishita Y, Kubo Y,
  719. Maki M, Kasagi F, Kodama K, Macphee DG, Kyoizumi S. “The well-documented increases in malignant tumours
  720. in the A-bomb survivors have recently been supplemented by reports that non-cancer diseases, including
  721. cardiovascular disease, may also have <strong>increased in incidence with increasing radiation dose.
  722. Given that low-level inflammatory responses are widely accepted as a significant risk factor for
  723. such diseases, we undertook a
  724. </strong>detailed investigation of the long-term effects of ionizing radiation on the levels of the
  725. inflammatory markers C-reactive protein (CRP) and interleukin 6 (IL-6) in A-bomb survivors.” “Blood
  726. samples were taken from 453 participants in a long-term epidemiological cohort of A-bomb survivors.”
  727. <strong><hr /></strong>Higher CRP levels also correlated with age, male gender, body mass index and a
  728. history of myocardial infarction. After adjustments for these factors, <strong>CRP levels still appeared
  729. to have increased significantly with increasing radiation dose (about 28% increase at 1Gy,
  730. </strong>
  731. <hr />
  732. <strong><hr /></strong>
  733. <hr />
  734. <strong>“Our results appear to indicate that exposure to A-bomb radiation has caused significant
  735. increases in inflammatory activity that are still demonstrable in the blood of A-bomb survivors and
  736. which may lead to increased risks of cardiovascular disease and other non-cancer diseases.</strong>”
  737. </p>
  738. <p>
  739. Immunol Rev. 2000 Oct;177:52-67. <strong>Chemokines and chemokine receptors in inflammation of the
  740. nervous system: manifold roles and exquisite regulation.</strong> Huang D, Han Y, Rani MR, Glabinski
  741. A, Trebst C, Sorensen T, Tani M, Wang J, Chien P, O'Bryan S, Bielecki B, Zhou ZL, Majumder S, Ransohoff
  742. RM.
  743. </p>
  744. <p>
  745. Am J Med Genet. 1989 Dec;34(4):562-8. <strong>Mortality rate of amyloidosis in Japan: secular trends and
  746. geographical Variations.</strong> Imaizumi Y. “The death rate in Japan from amyloidosis was analyzed
  747. using Japanese Vital Statistics for 1969-1985. <strong>The amyloidosis death rate has increased
  748. gradually year by year for both sexes.</strong>” “The mean age at death from amyloidosis gradually
  749. increased year by year for both sexes, although the age was <strong>11-23 years shorter for males and
  750. 20-25 years shorter for females</strong> than that of the general population.”
  751. </p>
  752. <p>
  753. Stroke. 1991 Nov;22(11):1448-51. <strong>Platelet secretory products may contribute to neuronal
  754. injury.</strong> Joseph R, Tsering C, Grunfeld S, Welch KM.
  755. </p>
  756. <p>
  757. J Neurochem. 1997 Jul; 69(1): 266-72.<strong>
  758. Aggregation of beta-amyloid peptide is promoted by membrane phospholipid metabolites elevated in
  759. Alzheimer's disease brain.</strong> Klunk WE, Xu CJ, McClure RJ, Panchalingam K, Stanley JA,
  760. Pettegrew JW. “A beta peptides have been shown to be toxic to neurons in cell culture, and this toxicity
  761. is critically dependent on the aggregation of the peptide into cross-beta-pleated sheet fibrils. Also,
  762. in vivo and postmortem NMR studies have shown changes in certain brain membrane phospholipid metabolites
  763. in normal aging and more extensive alterations in patients with Alzheimer's disease. The finding that
  764. membrane phospholipids affect the aggregation of A beta suggests that the abnormalities in membrane
  765. metabolism found in Alzheimer's disease could affect the deposition of A beta in vivo.” “Certain
  766. metabolites (glycerophosphocholine, glycerophosphoethanolamine, and alpha-glycerophosphate) augment the
  767. aggregation of A beta. Other membrane phospholipid metabolites (phosphocholine, phosphoethanolamine, and
  768. inositol-1-phosphate) have no effect.<strong></strong>We conclude that increased membrane phospholipid
  769. metabolite concentrations may play a role in the deposition of A beta seen in normal aging and the even
  770. greater deposition of A beta observed in Alzheimer's disease.”<strong></strong>
  771. </p>
  772. <p>
  773. J Pharm Sci. 1971 Feb; 60(2): 167-80. <strong>Experimental modification of the chemistry and biology of
  774. the aging process.</strong> Kormendy CG, Bender AD.
  775. </p>
  776. <p>
  777. Radiobiologiia. 1990 May-Jun;30(3):317-20. <strong>[Cholesterol and fatty acids of the nuclei and
  778. chromatin of the rat thymus at long intervals following gamma irradiation]</strong> Kulagina TP.
  779. “The FFA content in the homogenate, nuclei and chromatin of rat thymus drastically increased 60 min
  780. after the last exposure. In a month, the FFA content of nuclei and chromatin dropped to control levels,
  781. whereas that of the homogenate remained high throughout the entire period of observation and sharply
  782. increased by the third month.”
  783. </p>
  784. <p>
  785. J Neuropathol Exp Neurol. 1968 Jan; 27(1): 157-8.<strong>
  786. Amyloid in late postradiation necrosis of brain.</strong> Mandybur TJ, Gore y.
  787. </p>
  788. <p>
  789. Hepatology. 1995 Dec;22(6):1754-62. <strong>Effect of donor age and sex on the outcome of liver
  790. transplantation.</strong> Marino IR, Doyle HR, Aldrighetti L, Doria C, McMichael J, Gayowski T, Fung
  791. JJ, Tzakis AG, Starzl TE.
  792. </p>
  793. <p>
  794. Brain Res. 673(1), 149-152, 1995. <strong>"Glucose deprivation increases aspartic acid release from
  795. synaptosomes of aged mice,"</strong>M. Martinez, et al., "...in the absence of glucose in the medium
  796. of incubation aspartate and glutamate release was higher in old than in young animals." "...<strong
  797. >there is an age-dependent dysfunction in this process linked to energy metabolism disturbance</strong
  798. >."
  799. </p>
  800. <p>
  801. Neurobiol Aging. 1995 Nov-Dec; 16(6): 977-81. <strong>Estrogen induction of glial heat shock proteins:
  802. implications for hypothalamic Aging.</strong> Mydlarski MB, Liberman A, Schipper HM. “In the aging
  803. mammalian hypothalamus, a unique subpopulation of glial cells accumulates peroxidase-positive
  804. cytoplasmic inclusions distinct from lipofuscin. In adult rodents, this senescence-dependent glial
  805. granulation is accelerated by administration of estradiol valerate.” “<strong>Our findings indicate that
  806. estrogen elicits a heat shock response and subsequent granulation in astrocytes</strong> residing in
  807. estradiol receptor-rich brain regions including the arcuate nucleus and the wall surrounding the third
  808. ventricle but not in estradiol receptor-deficient regions such as the striatum and corpus callosum. The
  809. heat shock proteins induced by estrogen, namely, the 27, 72, and 90 kDa stress proteins, are upregulated
  810. in astrocytes in response to oxidative challenge supporting our hypothesis that estrogen mediates
  811. senescent changes in the rodent hypothalamus through oxidative mechanisms.”
  812. </p>
  813. <p>
  814. Proc. Natl. Acad. Sci. USA, vol. 44, pp. 712-717 (1958): <strong>"Epigenetic Control Systems".</strong>
  815. D. L. Nanney.
  816. </p>
  817. <p>
  818. Journal of the Neurological Sciences 1995;134:61-6.<strong>
  819. Mortality from motor neuron disease in Japan, 1950-1990: association with radioactive fallout from
  820. atmospheric weapons testing.
  821. </strong>Neilson S, Robinson I, Rose FC.
  822. </p>
  823. <p>
  824. Biol Psychiatry. 2002 Nov 1;52(9):880-6. <strong>Nicotine breaks down preformed Alzheimer's beta-amyloid
  825. fibrils in vitro.</strong> Ono K, Hasegawa K, Yamada M, Naiki H. “The antiamyloidogenic effect of
  826. nicotine may be exerted not only by the inhibition of fAbeta formation but also by the disruption of
  827. preformed fAbeta.”
  828. </p>
  829. <p>
  830. Res Immunol. 1998 Sep-Oct; 149(7-8): 721-5. <strong>The contribution of inflammation to acute and
  831. chronic neurodegeneration.</strong> Perry VH, Bolton SJ, Anthony DC, Betmouni S.<strong></strong>
  832. </p>
  833. <p>
  834. <strong>
  835. Neurology. 1966 Oct;16(10):957-62. Myxedema and ataxia. Cerebellar alterations and "neural myxedema
  836. bodies".
  837. </strong> Price TR, Netsky MG.
  838. </p>
  839. <p>
  840. Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):1580-5. Epub 2003 Feb 03. <strong>
  841. Short-term administration of omega 3 fatty acids from fish oil results in increased transthyretin
  842. transcription in old rat hippocampus.</strong> Puskas LG, Kitajka K, Nyakas C, Barcelo-Coblijn G,
  843. Farkas T.
  844. </p>
  845. <p>
  846. Arch Biochem Biophys. 2002 Apr 1;400(1):43-7. <strong>Inhibition of transthyretin amyloid fibril
  847. formation by 2,4-dinitrophenol through tetramer stabilization.
  848. </strong>Raghu P, Reddy GB, Sivakumar B.
  849. </p>
  850. <p>
  851. Br J Ind Med. 1992 Apr;49(4):233-40. <strong>Chronic encephalopathies induced by mercury or lead:
  852. aspects of underlying cellular and molecular mechanisms.</strong> Ronnback L, Hansson E.
  853. </p>
  854. <p>
  855. Radiat Res. 1967 Mar; 30(3): 640-53. <strong>Radiation studies on mice of an inbred tumor-resistant
  856. strain. The alteration of endogenous susceptibility to amyloidosis by x-irradiation.</strong>
  857. Rosenblum WI, Goldfeder A, Ghosh AK.
  858. </p>
  859. <p>
  860. Neurotoxicology 15(3), 493-502, 1994.<strong>"Phosphoinositide second messengers in cholinergic
  861. excitotoxicity,"</strong> K. Savolainen, et al. "Acetylcholine is a powerful excitotoxic
  862. neurotransmitter in the brain. By stimulating calcium-mobilizing receptors, acetylcholine, through
  863. G-proteins, stimulates phospholipase C and cause the hydrolysis of a membrane phospholipid...."Female
  864. sex and senescence increase the sensitivity of rats to cholinergic excitotoxicity."
  865. </p>
  866. <p>
  867. Int J Radiat Oncol Biol Phys. 1995 Jan 1;31(1):57-64. <strong>Radiation-induced changes in the profile
  868. of spinal cord serotonin, prostaglandin synthesis, and vascular permeability.</strong> Siegal T,
  869. Pfeffer MR. “Serotonin levels were unchanged at 2, 14,<strong></strong>and 56 days after radiation but
  870. increased at 120 and 240 days in the irradiated cord segments when compared to both the nonirradiated
  871. thoracic and cervical segments (p &lt; 0.01) and age-matched controls (p &lt; 0.03).<strong>”
  872. </strong>“In the first 24 h after radiation, a 104% increase in microvessel permeability was observed
  873. which returned to normal by 3 days. Normal permeability was maintained at 14 and 28 days, but at 120 and
  874. 240 days a persistent and significant increase of 98% and 73% respectively above control level was
  875. noted.”
  876. </p>
  877. <p>
  878. Annual Meeting of the American Psychological Association, New York, New York, September 3, 1979, <strong
  879. >"Fallout and the Decline of Scholastic Aptitude Scores,"</strong> Ernest Sternglass and Stephen Bell.
  880. </p>
  881. <p>
  882. Acta Neuropathol (Berl). 1995; 90(2): 135-41. <strong>Cerebral beta amyloid deposition in patients with
  883. malignant neoplasms: its prevalence with aging and effects of radiation therapy on vascular
  884. amyloid.</strong> Sugihara S, Ogawa A, Nakazato Y, Yamaguchi H. “The prevalence of cerebral A beta
  885. deposits was about two times higher in the patients who had received brain radiation therapy (27.8%)
  886. compared to non-radiated patients (14.8%). Amyloid angiopathy was much more prominent (P &lt; 0.05) with
  887. radiation therapy (22.2%) than without (8.0%).”
  888. </p>
  889. <p>
  890. Diabetes. 2003 Dec;52(12):2882-7. <strong>Elevation of free fatty acids induces inflammation and impairs
  891. vascular reactivity in healthy subjects.</strong> Tripathy D, Mohanty P, Dhindsa S, Syed T, Ghanim
  892. H, Aljada A, Dandona P.
  893. </p>
  894. <p>
  895. Arterioscler Thromb Vasc Biol. 2003 Dec 29. <strong>Effect of Lower Dosage of Oral Conjugated Equine
  896. Estrogen on Inflammatory Markers and Endothelial Function in Healthy Postmenopausal Women.</strong>
  897. Wakatsuki A, Ikenoue N, Shinohara K, Watanabe K, Fukaya T. {Oral estrogen) “... <strong>increases plasma
  898. C-reactive protein (CRP) and interleukin-6 (IL-6) concentration.</strong> The proinflammatory effect
  899. of oral ERT may explain the increased risk of coronary heart disease (CHD) associated with this
  900. treatment.”
  901. </p>
  902. <p>
  903. Am J Pathol. 1997 Jun; 150(6): 2181-95. <strong>Free fatty acids stimulate the polymerization of tau and
  904. amyloid beta peptides.</strong>
  905. <strong>In vitro evidence for a common effector of pathogenesis in Alzheimer's disease.</strong> Wilson
  906. DM, Binder LI. “We have discovered that free fatty acids (FFAs) stimulate the assembly of both amyloid
  907. and tau filaments in vitro.” <strong>“Utilizing fluorescence spectroscopy, unsaturated FFAs were also
  908. demonstrated to induce beta-amyloid assembly.</strong>” [These results] “...suggest that cortical
  909. elevations of FFAs may constitute a unifying stimulatory event driving the formation of two of the
  910. obvious pathogenetic lesions in Alzheimer's disease.”
  911. </p>
  912. <p>
  913. Lab Invest. 2001 Apr; 81(4): 493-9. <strong>Transmission of mouse senile amyloidosis.</strong> Xing Y,
  914. Nakamura A, Chiba T, Kogishi K, Matsushita T, Li F, Guo Z, Hosokawa M, Mori M, Higuchi K. “In mouse
  915. senile amyloidosis, apolipoprotein A-II polymerizes into amyloid fibrils (AApoAII) and deposits
  916. systemically. Peripheral injection of AApoAII fibrils into young mice induces systemic amyloidosis....”
  917. “We isolated AApoAII amyloid fibrils from the livers of old R1.P1-Apoa2(c) mice and injected them with
  918. feeding needles into the stomachs of young R1.P1-Apoa2(c) mice for 5 consecutive days. After 2 months,
  919. all mice had AApoAII deposits in the lamina propria of the small intestine. Amyloid deposition extended
  920. to the tongue, stomach, heart, and liver at 3 and 4 months after feeding. AApoAII suspended in drinking
  921. water also induced amyloidosis.” “Amyloid deposition was induced in young mice reared in the same cage
  922. for 3 months with old mice who had severe amyloidosis. Detection of AApoAII in feces of old mice and
  923. induction of amyloidosis by the injection of an amyloid fraction of feces suggested the propagation of
  924. amyloidosis by eating feces. Here, we substantiate the transmissibility of AApoAII amyloidosis and
  925. present a possible pathogenesis of amyloidosis, ie, oral transmission of amyloid fibril conformation,
  926. where we assert that exogenous amyloid fibrils act as templates and change the conformation of
  927. endogenous amyloid protein to polymerize into amyloid fibrils.”
  928. </p>
  929. </article>
  930. </body>
  931. </html>